Steven Cohen's PRQR Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 755,842 shares of ProQR Therapeutics N.V. (PRQR) worth $1.22 M, representing 0.00% of the portfolio. First purchased in 2015-Q1, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in PRQR, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2021, adding 1.52 M shares. Largest reduction occurred in Q2 2021, reducing 1.52 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's ProQR Therapeutics NV (PRQR) Holding Value Over Time
Track share changes against reported price movement
Quarterly ProQR Therapeutics NV (PRQR) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -57,808 | Reduce 7.10% | 755,842 | $1.62 |
| Q4 2025 | +63,650 | Add 8.49% | 813,650 | $2.02 |
| Q1 2025 | -741,275 | Reduce 49.71% | 750,000 | $1.33 |
| Q4 2024 | +1.49 M | New Buy | 1.49 M | $2.65 |
| Q1 2022 | -461,000 | Sold Out | 0 | $0.00 |
| Q4 2021 | +3,100 | Add 0.68% | 461,000 | $8.01 |
| Q3 2021 | +457,900 | New Buy | 457,900 | $8.37 |
| Q2 2021 | -1.52 M | Sold Out | 0 | $0.00 |
| Q1 2021 | +1.52 M | New Buy | 1.52 M | $6.61 |
| Q3 2015 | -100 | Sold Out | 0 | $0.00 |
| Q2 2015 | -2,400 | Reduce 96.00% | 100 | $20.00 |
| Q1 2015 | +2,500 | New Buy | 2,500 | $22.00 |
Steven Cohen's ProQR Therapeutics NV Investment FAQs
Steven Cohen first purchased ProQR Therapeutics N.V. (PRQR) in Q1 2015, acquiring 2,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held ProQR Therapeutics N.V. (PRQR) for 14 quarters since Q1 2015.
Steven Cohen's largest addition to ProQR Therapeutics N.V. (PRQR) was in Q1 2021, adding 1,521,800 shares worth $10.06 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 755,842 shares of ProQR Therapeutics N.V. (PRQR), valued at approximately $1.22 M.
As of the Q1 2026 filing, ProQR Therapeutics N.V. (PRQR) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in ProQR Therapeutics N.V. (PRQR) was 1,521,800 shares, as reported at the end of Q1 2021.